Farmers Trust Co. Has $1.18 Million Stock Position in Stryker Co. (NYSE:SYK)

Farmers Trust Co. cut its holdings in Stryker Co. (NYSE:SYK) by 2.9% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,271 shares of the medical technology company’s stock after selling 98 shares during the quarter. Farmers Trust Co.’s holdings in Stryker were worth $1,178,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of SYK. Dunhill Financial LLC boosted its position in Stryker by 94.9% in the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Centennial Bank AR increased its holdings in Stryker by 106.7% in the 2nd quarter. Centennial Bank AR now owns 93 shares of the medical technology company’s stock worth $32,000 after purchasing an additional 48 shares in the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Stryker during the third quarter valued at about $36,000. Hara Capital LLC acquired a new position in shares of Stryker in the third quarter valued at approximately $42,000. Finally, HBW Advisory Services LLC acquired a new stake in Stryker during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on SYK shares. JPMorgan Chase & Co. upped their price target on shares of Stryker from $375.00 to $420.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a research report on Tuesday. Canaccord Genuity Group upped their price target on Stryker from $360.00 to $400.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. StockNews.com downgraded Stryker from a “buy” rating to a “hold” rating in a research report on Wednesday, January 1st. Finally, Wells Fargo & Company raised their price target on shares of Stryker from $405.00 to $427.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average price target of $405.80.

Stryker Stock Up 2.3 %

NYSE SYK traded up $8.29 during trading hours on Wednesday, hitting $363.47. The company’s stock had a trading volume of 886,393 shares, compared to its average volume of 1,128,079. The company has a current ratio of 1.91, a quick ratio of 1.22 and a debt-to-equity ratio of 0.66. The company’s 50-day simple moving average is $375.25 and its two-hundred day simple moving average is $357.42. The company has a market capitalization of $138.56 billion, a PE ratio of 38.96, a price-to-earnings-growth ratio of 2.82 and a beta of 0.95. Stryker Co. has a 52 week low of $298.52 and a 52 week high of $398.20.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.10. The business had revenue of $5.49 billion during the quarter, compared to the consensus estimate of $5.37 billion. Stryker had a return on equity of 23.07% and a net margin of 16.34%. Stryker’s revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.46 earnings per share. Research analysts anticipate that Stryker Co. will post 12.06 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.92%. This is an increase from Stryker’s previous quarterly dividend of $0.80. The ex-dividend date of this dividend is Tuesday, December 31st. Stryker’s dividend payout ratio is presently 36.01%.

Insiders Place Their Bets

In other Stryker news, CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the sale, the chief executive officer now owns 100,027 shares of the company’s stock, valued at approximately $36,879,954.90. The trade was a 36.43 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 5.50% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.